Leadership Team

Travis Gay serves as President and General Manager of Teleflex Interventional Urology. Travis most recently served as Co-founder and Chief Commercial Officer of Palette Life Sciences, formally joining Teleflex in October 2023 as Chief Technology Officer, Interventional Urology, upon the completion of Teleflex’s acquisition of Palette. Over the past 10 years, Travis led the developmental efforts of Palette Life Sciences by transforming proprietary innovations in medical technology into commercial viable solutions. Travis’ commercial expertise and leadership roles were shaped through roles as founder, CEO, Vice President, Sales, and Director of Global Marketing in the Oncology and Urology world for Core Oncology, Mentor, UroCor, Healthsense, and Physician Sales & Service. He is a graduate of the Executive Education Program at the UCLA Anderson School of Management.

Anthony serves as Vice President of Global Marketing for Teleflex Interventional Urology. Anthony brings 22 years of sales and marketing experience across consumer goods and the medical device industry. He most recently served as Vice President of Therapy Development and Marketing for Butterfly Network, a handheld ultrasound solution, where he led upstream, downstream, digital marketing, and e-commerce functions. Prior to that, Anthony spent 11 years at Boston Scientific in various sales and marketing roles, most recently as the Global Franchise Leader and Marketing Director for the Prostate Health franchise. He led the integration, portfolio strategy, and growth for the three products within the franchise. He holds a Bachelor’s of Science degree from Purdue University.

Jacqueline Welch serves as Vice President of Teleflex’s Global Clinical Operations and Scientific Services and has been with the company since November 2004. She also serves as Medical Director for Teleflex Interventional Urology. Prior to joining Teleflex, Dr. Welch pursued research and innovation through a variety of technology and clinical roles at Stanford University, Exploramed, Guidant, Pfizer, NASA Ames Research Center, Lawrence Livermore National Laboratory and Lawrence Berkeley National Laboratory. Dr. Welch is an affiliate member of the American Urological Association and serves as the industry representative of the Gastroenterology and Urology Devices Panel of the Food and Drug Administration. Dr. Welch holds an M.D. from Stanford University and B.S., M.S., and Ph.D. in Mechanical Engineering from Stanford University.

Trey joined NeoTract | Teleflex in 2014 as one of the first members of the sales team holding leadership positions as Regional Business Manager and Area Sales Director. With more than 14 years of urology medical device sales experience, Trey’s extensive knowledge of reimbursement, U.S. health care partners, and several years of experience leading territories across Interventional Urology’s sales footprint, helps strengthen UroLift’s sales strategy. Prior to joining Interventional Urology, Trey held sales positions with Bard and Medtronic. He holds a B.A. in Management & Marketing from the Lindenwood University in St. Louis, Mo.

Brian Wilkins joined Teleflex Interventional Urology as Vice President, Research and Development in August 2022. He brings more than 25 years of experience in the medical device industry, designing, developing, and commercializing medical devices to solve unmet needs primarily focused on vascular disease. Over the past two decades, Brian held multiple R&D roles at Cordis Corporation, most recently serving as Director of Research and Development. In addition, Brian has extensive experience working with global OEMs and evaluating new medical device technologies. Brian holds an M.B.A from University of California, Berkeley Haas School of Business and an M.S. in Biomedical Engineering from Tulane University.

Jen Dallaire is the Vice President, Finance, Teleflex Interventional Urology. She has more than 20 years of financial experience with Teleflex. Jen has held numerous roles of substantial responsibility throughout her career with Teleflex, including Vice President of Finance for the Surgical Business Unit and, most recently, Vice President of Finance for the Interventional Business Unit. Jen was named Vice President of Finance for Interventional upon completing the VSI acquisition. Jen holds a B.S. in Accounting from the University of Massachusetts Dartmouth.